Welcome to the vector analytics webinar hub
When you are developing viral or non-viral delivery platforms for vaccines, gene therapies, or phage-based treatments you need to apply the right technologies and expertise to ensure these delivery vectors help your treatments reach their full potential. Explore our webinars, where you’ll find insights, tips and advice from technology and application experts.
Vector analytics masterclass
Join our team of characterization experts as they dive deep into the methodologies you need for successful vector development. They’ll also show you how to generate robust measurements and help you understand how a holistic approach to generating data analysis will give you greater confidence in your results.
Strategies for viral and non-viral vectors characterization
Using zeta potential for the surface characterization of viral and lipid-based vectors
How to use SEC-SLS and other detectors to understand mRNA vector composition
How differential scanning calorimetry can improve the thermal stability of lipid-based vectors
Lipid nanoparticles for drug delivery
mRNA-LNP biophysical characterization
Developing drugs as complex as mRNA-LNPs requires a customized analytical toolkit of methods and technologies. Join our expert team as we explore biophysical characterization for mRNA LNPs.
mRNA-LNP biophysical characterization with microcalorimetry
How to run mRNA-LNP measurements on MicroCal PEAQ-DSC
Master Lipid Nanoparticle & Liposome Characterization with Light Scattering
Transform vaccine production with these nanoparticle characterization techniques
Key Considerations for characterizing LNPs
Understanding and Controlling Stability of LNPs Using DLS and NTA
The Role of Charge in the Formulation of LNPs
AAV formulation development: Extend serotype characterization with OMNISEC
Accelerate AAV Analysis with OMNISEC: viral titer and capsid empty/full ratios
Eliminate bottlenecks in biopharmaceutical characterization - OMNISEC reveals all
Streamline pharmaceutical development with advanced analytics
Finding fit-for-purpose analytics: AAV characterization and formulation development
Focus on vaccine development
Discover the latest characterization tools that can be applied to virus and vaccine studies with insights from practicing experts in this four-part webinar series.
Focus on Vaccines 1: Characterizing a protein antigen
Focus on Vaccines 2/4: How stable is stable?
Focus on Vaccines 3/4: Increasing development efficiency
Focus on Vaccines 4/4: Vaccine and VLP characterization
Exploring advanced biophysical characterization techniques
Malvern Panalytical has launched a collaboration with small-angle X-ray scattering specialists Xenocs to explore how complementary analytical solutions will give you deeper insights into the structural features of your biopharmaceuticals.
Join our biophysical characterization and biopharmaceutical experts to dive into applications around nucleic acid drug products (such as mRNA vaccines and RNA therapeutics), as well as biopharmaceuticals, including peptide-based therapeutics.